Two closely watched genetic sequencing technology firms who had been unhappily affiliated have now divorced. UK-based Oxford Nanopore announced on 15 November that it has raised £56.4 million – mostly by selling the 13.5% of its shares that had been owned by San Diego-based Illumina since 2009. Read more
Roche has backed off of its hostile takeover bid for Illumina. The move came after Illumina shareholders rebuffed Roche’s efforts to install board members favorable to a merger at the San Diego-based gene sequencing technology company’s 18 April annual meeting. Read more
The board of directors of San Diego-based Illumina today rejected a takeover bid launched by Basel, Switzerland-based Roche. The move by Illumina, which estimates that its machines produce 90 percent of the world’s genetic sequencing output, was not surprising, given the company’s earlier moves to deter the offer. Read more
Recent comments on this blog
Experiments reveal that crabs and lobsters feel pain
US research ethics agency upholds decision on informed consent
Chemistry credit disputes under the spotlight
Chemistry credit disputes under the spotlight
Contamination created controversial ‘acid-induced’ stem cells